Home Search
Parkinson’s disease - search results
If you're not happy with the results, please do another search
Getting enough sleep is vital for healthy ageing
Dr Deborah Lee from Dr Fox Online Pharmacy analyses insomnia in the UK and why getting enough sleep is vital for healthy ageing.
How can speech recognition redefine patient care?
Speech recognition solutions could tackle the administrative burden of clinical documentation, and help deliver better-informed patient treatment.
Killing cancer softly: The resolution of cancer lies in tumor cells
Dr Dipak Panigrahy, M.D., an Assistant Professor at Harvard Medical School looks at killing tumor cells to resolve the cancer epidemic.
The Immune system in Human Biology
Experts from Oxford Immune Algorithmics highlight how the Immune system has come under the spotlight in Human Biology, particularly as a consequence of the COVID-19 pandemic.
Drone chemotherapy becomes an NHS net zero cancer strategy
NHS cancer patients will be the first to experience drone chemotherapy, which furthers the NHS net zero strategy, as it cuts down travel time and distance.
Improving the lives of people with brain disorders
European Brain Council outlines the priorities for the future when it comes to improving the lives of people with brain disorders.
Digital biomarker predicts mild cognitive impairment conversion to Alzheimer’s
Digital biomarker can identify which cases of mild cognitive impairment will develop into Alzheimer’s so that early interventions can be put in place to prevent the onset of the disease.
Prof Monica Di Luca – European Brain Council
Monica Di Luca, Past President, EBC Coordinator and EBRA-project, is Professor of Pharmacology, Director of NeuroNest (Center of Neuroscience) and Head of Laboratory of Pharmacology of Neurodegeneration – DiSFeB at the University of Milano.
Understanding the brain: hope for neuroscience research
Advancing neuroscience research improves quality of life for all people with neurological disorders, and ultimately can prevent or cure these diseases. Open Access Government highlight some research priorities in neuroscience.
Amyloid oligomer & membrane channel structures
H. Robert Guy, CEO from Amyloid Research Consultants, ascertains why amyloid oligomer & membrane channels structures can & must be determined.
Next-generation digital tools for mobility in research & health
Beatrix Vereijken and Lynn Rochester share how Mobilise-D develops digital technology to measure mobility in daily life to transform clinical research and health.
What are the benefits of dancing?
Dr Deborah Lee, Dr Fox Online Pharmacy, discusses the benefits of dancing on your general health.
The impact and importance of psychedelic medicine
Here, we discover the impact and importance of psychedelic medicine through the eyes of Amanda Feilding, Director of The Beckley Foundation.
Patient and Public Involvement at the heart of brain research
Professor Mogens Hørder, PPI expert, JPND’s management board member and representative of member state Denmark, discusses how Patient and Public Involvement (PPI) is at the heart of neurodegenerative disease research.
How do environmental factors affect foetal development?
Associate Professor Ken Tachibana, discloses how prenatal ambient fine particle exposure disrupts DNA methylation and subsequent gene expression in the foetal development stage.
Tackling the impacts of pesticides on human, animal and environmental health
Jane Mills, University of Gloucestershire, tells us about the SPRINT project’s aim to tackle the impacts of pesticides on human, animal and environmental health.
Shaping the future of research into epilepsy
There are 21 epilepsy-related deaths every week in the UK - here, Maxine Smeaton, Chief Executive of Epilepsy Research UK discusses what the future holds for essential epilepsy treatment research.
Targeted policy support for emerging biomedical innovations
Michael Morrison, Senior Researcher in Social Science at the University of Oxford, illustrates the importance of emerging biomedical innovations in the UK.
CBD: Narcotic substance or a novel food product?
CBD is at the forefront of pharmacology. So why has the European Commission changed its recommended status to “Narcotic”? Read on to find out more.
How cannabinoids can be used as pain medicine
Dr Daniela Tonucci, a consultant for over 10 years, talks us through the use of cannabinoids as pain medicine.
